Skip to main content
. 2020 Aug 22;11(8):697. doi: 10.1038/s41419-020-02891-2

Fig. 1. Virtual screening process and in vitro screening.

Fig. 1

a Flowchart of structure-based virtual screening for RORγt inverse agonist discovery. b Representative graphs of multiple screening results of CQMU151 and CQMU152 at a concentration of 5, 10, 25, 50, and 100 μM. c, d Statistics of three repeated experiments of CQMU151 and CQMU152 at concentrations of 10, 50, and 100 μM (*P < 0.05, **P < 0.01 versus the control group with Student’s t-test, n = 3).